Fwd: EBRD says YES to Ukraine

---------- Forwarded message ----------
From: European Bank for Reconstruction and Development <EBRD@public.govdelivery.com>
Date: Thu, Sep 11, 2014 at 4:06 AM
Subject: EBRD says YES to Ukraine
To: iammejtm@gmail.com

You are subscribed to Press Releases for European Bank for Reconstruction and Development. This information has recently been updated, and is now available. EBRD says YES to Ukraine 11-09-2014 12:00 AM BST   Questions? Contact us or go to ebrd.com. You can also find us on Facebook, Twitter and Linkedin.   SUBSCRIBER SERVICES: Manage Preferences  |  Delete profile  |  Help This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: European Bank for Reconstruction and Development · One Exchange Square · London EC2A 2JN · United Kingdom · +44 020 7338 6000

--
Jeremy Tobias Matthews

Fwd: Regeneca Worldwide, a Division of Vivaceuticals, Inc Expands the Voluntarily Recall of Regeneslim Appetite Control Capsules Due to the Presence of DMAA that May Pose Possible Health Risk

---------- Forwarded message ----------
From: U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com>
Date: Mon, Sep 1, 2014 at 10:15 AM
Subject: Regeneca Worldwide, a Division of Vivaceuticals, Inc Expands the Voluntarily Recall of Regeneslim Appetite Control Capsules Due to the Presence of DMAA that May Pose Possible Health Risk
To: iammejtm@gmail.com

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Regeneca Worldwide, a Division of Vivaceuticals, Inc Expands the Voluntarily Recall of Regeneslim Appetite Control Capsules Due to the Presence of DMAA that May Pose Possible Health Risk

08/29/2014 10:38 PM EDT

Regeneca Worldwide a division of VivaCeuticals, Inc. Las Vegas, NV is expanding the voluntary nationwide recall of its RegeneSlim appetite control dietary supplement to include lot #823230415, lot #EX0616r 15813, Lot # EX0616R15814 and Lot #11414re5516 because FDA analysis confirmed the presence of DMAA. DMAA is also known as 1,3-dimethylamylamine, methylhexanamine, or geranium extract. DMAA is commonly used as a stimulant, pre-workout, and weight loss ingredient in dietary supplement products.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420

--
Jeremy Tobias Matthews

Fwd: Securities and Exchange Commission - Notice of Effectiveness from the Division of Corporation Finance Update

---------- Forwarded message ----------
From: Securities and Exchange Commission <sec@service.govdelivery.com>
Date: Tue, Sep 2, 2014 at 3:05 AM
Subject: Securities and Exchange Commission - Notice of Effectiveness from the Division of Corporation Finance Update
To: iammejtm@gmail.com

You are subscribed to receive information about Notice of Effectiveness from the Division of Corporation Finance of the Securities and Exchange Commission.

This information has recently been updated and is now available.

http://sec.gov/cgi-bin/browse-edgar?action=geteffect

 

 

You can update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. For more information on collecting personally identifiable information, please read the SEC's privacy policy. Manage Preferences | Delete Profile | Help

This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: Securities and Exchange Commission · 100 F Street, NE · Washington, DC 20549 · 202-551-4120

--
Jeremy Tobias Matthews